Quick Search:

is currently disabled due to reindexing of the ZORA database. Please use Advanced Search.
uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-3622

Siegrist, P T; Husmann, L; Knabenhans, M; Gaemperli, O; Valenta, I; Hoefflinghaus, T; Scheffel, H; Stolzmann, P; Alkadhi, H; Kaufmann, P A (2008). (13)N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. European Journal of Nuclear Medicine and Molecular Imaging, 35(5):889-895.

[img] PDF - Registered users only
1MB

Abstract

PURPOSE: The purpose of the study is to determine the impact of 13N-ammonia positron emission tomography (PET) myocardial perfusion imaging (MPI) on clinical decision making and its cost-effectiveness. MATERIALS AND METHODS: One hundred consecutive patients (28 women, 72 men; mean age 60.9 +/- 12.0 years; range 24-85 years) underwent 13N-ammonia PET scanning (and computed tomography, used only for attenuation correction) to assess myocardial perfusion in patients with known (n = 79) or suspected (n = 8) coronary artery disease (CAD), or for suspected small-vessel disease (SVD; n = 13). Before PET, the referring physician was asked to determine patient treatment if PET would not be available. Four weeks later, PET patient management was reassessed for each patient individually. RESULTS: Before PET management strategies would have been: diagnostic angiography (62 of 100 patients), diagnostic angiography and percutaneous coronary intervention (PCI; 6 of 100), coronary artery bypass grafting (CABG; 3 of 100), transplantation (1 of 100), or conservative medical treatment (28 of 100). After PET scanning, treatment strategies were altered in 78 patients leading to: diagnostic angiography (0 of 100), PCI (20 of 100), CABG (3 of 100), transplantation (1 of 100), or conservative medical treatment (76 of 100). Patient management followed the recommendations of PET findings in 97% of the cases. Cost-effectiveness analysis revealed lower costs of <euro>206/patient as a result of PET scanning. CONCLUSION: In a population with a high prevalence of known CAD, PET is cost-effective and has an important impact on patient management.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine
04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Diagnostic and Interventional Radiology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2008
Deposited On:06 Oct 2008 10:46
Last Modified:27 Nov 2013 18:19
Publisher:Springer
ISSN:1619-7070
Publisher DOI:10.1007/s00259-007-0647-3
PubMed ID:18057933
Citations:Web of Science®. Times Cited: 14
Google Scholar™
Scopus®. Citation Count: 17

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page